莫达非尼(modafinil)是一种新型中枢兴奋剂,于1994年后相继在法国、英国、德国上市,于1998年10月24日由美国FDA正式批准上市,按4类管制药品管理[1]。2008年3月14日莫达非尼被列入SFDA发布的兴奋剂目录公告[2]。莫达非尼用于治疗发作性睡病相关的日间过度嗜睡、特发性过度睡眠病 Modafinil, a new type of central stimulant, was listed in France, Britain and Germany successively after 1994 and was formally approved by the FDA on October 24, 1998. According to the four categories of controlled drugs [1 ]. March 14, 2008 Modafinil is included in the list of stimulants released by SFDA [2]. Modafinil for the treatment of narcolepsy related to excessive daytime sleepiness, idiopathic sleep disorders